Inspire Medical Systems, Inc.

NYSE:INSP

Market Cap

USD 4.11 B

Share Price

USD 130.26

Avg Daily Volume

535,198

Change (1 day)

-6.46%

Change (1 year)

-3.96%

Change (YTD)

-29.73%

Inspire Medical Systems, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 9.27%

Inspire Medical Systems, Inc. EBITDA Margin is 9.27% for the Trailing 12 Months (TTM) ending March 31, 2025, a -321.03% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Inspire Medical Systems, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -4.20%, a -58.06% change year over year.
  • Inspire Medical Systems, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -10.01%, a -31.74% change year over year.
  • Inspire Medical Systems, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -14.66%, a -63.52% change year over year.
  • Inspire Medical Systems, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -40.18%, a -9.03% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin